Mandate

Nextmune acquires Dr Baddaky Europe

April 11, 2018 Banking and Finance

Vinge and BA-HR have advised Nextmune AB in connection with the acquisition of Dr Baddaky Europe. 

Nextmune is a leading European company engaged in providing allergy diagnostics and allergy treatment of companion animals.

Vinge’s team consisted of, among others, Jonas Bergström and Johanna Wiberg.

Related

Vinge advises Axcel and XPartners in connection with the acquisition of HTJ

Vinge has advised Axcel VII (“Axcel”) and XPartners Samhällsbyggnad (”XPartners”) in connection with the acquisition of HTJ Holding OY and its subsidiary Rakennuttajatoimisto HTJ Oy (”HTJ”).
June 13, 2024

Vinge has assisted Priveq in connection with the formation of Priveq Investment VII

Priveq, a leading Nordic lower mid-market growth and buyout investor, has closed its seventh fund, Priveq Investment VII, at SEK 3 billion. The fund’s first and final closing was significantly oversubscribed with strong backing from existing investors and substantial interest from new institutional investors.
June 04, 2024

Vinge advises Vinci Concessions SAS and its subsidiary SunMind SAS in connection with its acquisition of Helios Nordic Energy AB from Magnora ASA, management and early investors

Helios Nordic Energy specialises in developing solar farms and batteries to store energy until they become Ready to Build in the Nordics and Baltics.
May 30, 2024